CureMeAbroad raises $600K in pre-seed funding round
This Pune based company aims to expand its presence in key source regions including the GCC, United Kingdom, and Africa.
Medical tourism discovery startup CureMeAbroad has secured $600,000 in a pre-seed funding round.
The round was backed by investors including Roman Saini, Himanshu Ratnoo, Kunal Gupta, Devaiah Bopanna, and Vikrant Potnis.
The company plans to deploy the capital toward strengthening its technology stack, with a focus on enhancing its AI-powered pricing engine, improving clinical matching capabilities, and scaling its multilingual patient intelligence systems that drive its discovery platform.
Founded in June 2025 by Aditya Oza and Mikhail Bohra, CureMeAbroad is building an AI-led marketplace that helps international patients identify and connect with hospitals, doctors, and treatment destinations globally.
The platform is designed to streamline cross-border healthcare access in a sector often hindered by fragmented information and lack of pricing transparency.
At the core of its offering is a proprietary cost estimation engine trained on hundreds of medical procedures, enabling patients to access upfront pricing insights. The platform also integrates clinical matching models to recommend appropriate providers based on patient requirements, while maintaining compliance with global healthcare data standards.
CureMeAbroad has aggregated a network of thousands of hospitals across dozens of countries and multiple specialties, while also partnering with accredited healthcare providers in key medical tourism destinations such as Mexico, Turkey, Thailand, India, and Georgia. Its model focuses on replacing agent-led workflows with a more transparent and data-driven approach.
Within a short period of launch, the startup has reported strong early traction, reaching a multi-million dollar annual revenue run rate and catering to high-value treatment cases across global markets.
Looking ahead, CureMeAbroad aims to expand its presence in key source regions including the GCC, United Kingdom, and Africa. The company is positioning itself to address longstanding challenges in the medical tourism ecosystem, such as opaque pricing, unverified providers, and limited accountability in patient care journeys.
Operating in a growing global market projected to see significant expansion over the next decade, CureMeAbroad is focused on building a trusted digital infrastructure for international healthcare access while competing with platforms like Bookimed, PlacidWay, The Medical Tourism Company, and Medical Departures.